Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Goldman

Showing results (171-180 of 304) with videos related to

Pageof 31
Sort By:
Future Oncology (London, England)|May 7, 2025
Adverse events self-reported by patients with extensive-stage small-cell lung cancer in the phase III CASPIAN studyMustafa Özgüroğlu, Jonathan W Goldman, Yuanbin Chen, et al.
Arthritis Care & Research|February 22, 2023
Role of Platelet-Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus ErythematosusYevgeniya Gartshteyn, John Conklin, Michelle A Petri, et al.
Clinical Lung Cancer|March 5, 2023
Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2-IA3 EGFR-Mutated NSCLC: ADAURA2Yasuhiro Tsutani, Jonathan W Goldman, Sanja Dacic, et al.
Clinical Lung Cancer|July 18, 2017
Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)Daria Gaut, Myung Shin Sim, Yuguang Yue, et al.
Clinical Lung Cancer|May 9, 2025
Brief Report: The Genomic Landscape of Small Cell Lung Cancer in Never-Smoking PatientsMichael S Oh, Edward B Garon, Aaron E Lisberg, et al.
JCO Precision Oncology|March 14, 2024
Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric OncologyMichelle F Jacobs, Joshua W Goldman, Sarah Austin, et al.
International Journal of Cardiology|September 1, 2015
Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardiumSumanth C Suresh, Vaithinathan Selvaraju, Mahesh Thirunavukkarasu, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2001
Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institutionD W Andrews, O Suarez, H W Goldman, et al.
JTO Clinical and Research Reports|March 16, 2023
Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and OsimertinibClayton P Smith, Michael Xiang, Stephanie M Yoon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 15, 2024
Multiorgan transplant for therapy-associated lung and liver failure in a patient with stage III lung cancerAnitha Chandrasekhar, Hee Chul Yang, Tarik Demir, et al.
Pageof 31

Showing results (171-180 of 304) with videos related to

Sort By:
Pageof 31
Future Oncology (London, England)|May 7, 2025
Adverse events self-reported by patients with extensive-stage small-cell lung cancer in the phase III CASPIAN studyMustafa Özgüroğlu, Jonathan W Goldman, Yuanbin Chen, et al.
Arthritis Care & Research|February 22, 2023
Role of Platelet-Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus ErythematosusYevgeniya Gartshteyn, John Conklin, Michelle A Petri, et al.
Clinical Lung Cancer|March 5, 2023
Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2-IA3 EGFR-Mutated NSCLC: ADAURA2Yasuhiro Tsutani, Jonathan W Goldman, Sanja Dacic, et al.
Clinical Lung Cancer|July 18, 2017
Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)Daria Gaut, Myung Shin Sim, Yuguang Yue, et al.
Clinical Lung Cancer|May 9, 2025
Brief Report: The Genomic Landscape of Small Cell Lung Cancer in Never-Smoking PatientsMichael S Oh, Edward B Garon, Aaron E Lisberg, et al.
JCO Precision Oncology|March 14, 2024
Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric OncologyMichelle F Jacobs, Joshua W Goldman, Sarah Austin, et al.
International Journal of Cardiology|September 1, 2015
Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardiumSumanth C Suresh, Vaithinathan Selvaraju, Mahesh Thirunavukkarasu, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2001
Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institutionD W Andrews, O Suarez, H W Goldman, et al.
JTO Clinical and Research Reports|March 16, 2023
Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and OsimertinibClayton P Smith, Michael Xiang, Stephanie M Yoon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 15, 2024
Multiorgan transplant for therapy-associated lung and liver failure in a patient with stage III lung cancerAnitha Chandrasekhar, Hee Chul Yang, Tarik Demir, et al.
Pageof 31